Coronary disease & ACS

Epicardial Adipose Tissue, Coronary Plaque Progression, and Major Adverse Cardiovascular Events: A Multicenter Study

JACC Cardiovasc ImagingPublished Registry-based cohort study

Authors' conclusion

High EATv is independently associated with CAD presence and progression

Study context

Population
Patients with serial coronary CT angiography in the PARADIGM registry324 women [43%]
Participants
773 patients
Exposure
Epicardial adipose tissue (EAT) volume tertiles
Outcome
Association of EAT volume with plaque, plaque progression (PP) and rapid plaque progression (RPP; annual PAV increase ≥1%)
Methodological detailsserial coronary CT angiography
  • Serial coronary CT angiography

Main finding

As reported in the abstract

Prevalence of PP and RPP across EATv tertiles

PP

P = 0.013

RPP

P = 0.021

Observational data: associations, not effects.

Further findings

EATv by CAD presence

P < 0.001

OutcomeP value
Progression of PV, PAV, calcified and noncalcified plaque, T3 vs T1T3 vs T1 · PVP = 0.001
Progression of PV, PAV, calcified and noncalcified plaque, T3 vs T1T3 vs T1 · PAVP = 0.028
Progression of PV, PAV, calcified and noncalcified plaque, T3 vs T1T3 vs T1 · calcified componentP = 0.025
Progression of PV, PAV, calcified and noncalcified plaque, T3 vs T1T3 vs T1 · noncalcified componentP = 0.022

Progression of plaque volume (PV), percent atheroma volume (PAV), calcified and noncalcified plaque, T3 vs T1

Significantly greater progression in T3 than T1

10-year major adverse cardiovascular events (MACE)-free survival by plaque progression (PP) and rapid plaque progression (RPP)

Lower MACE-free survival with PP (log-rank)
P = 0.006
Lower MACE-free survival with RPP (log-rank)
P < 0.001

Original publication

Epicardial Adipose Tissue, Coronary Plaque Progression, and Major Adverse Cardiovascular Events: A Multicenter Study. JACC Cardiovasc Imaging. Published 10 March 2026. doi:10.1016/j.jcmg.2026.02.003

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.